Mental health consequences of contemporary cannabis use in Europe: potency, patterns of use, and health system context
By
Justyna Śniadach
Sylwia Szymkowiak
Przemysław Osip
Wiktor Orlof
Napoleon Waszkiewicz
June 10, 2026
Clinical Scorecard: Impact of Modern Cannabis Consumption on Mental Health in Europe: Potency, Usage Trends, and Healthcare Framework
At a Glance
Category Detail
Condition Key Mechanisms Target Population Adults in Europe, particularly young individuals and those with genetic/environmental vulnerabilities (source needed). Care Setting
Key Highlights
Cannabis use increased by 40-50% over the past decade in Europe (source needed). High-potency cannabis (>15-25% THC) is associated with higher psychiatric risks (specify risks). Guideline-Based Recommendations
Diagnosis
Improved diagnostic practices needed to identify cannabis-related psychiatric disorders (source needed). Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Late recognition of cannabis use disorder and delayed treatment are common (source needed).
Clinical Best Practices
Routine collection of psychiatric outcome data (source needed). Early identification of high-risk cannabis use (source needed). Related Resources & Content
